Deerfield Special Situations Fund, L.P.'s Net Worth

$486 Million

Who is Deerfield Special Situations Fund, L.P.?

Deerfield Special Situations Fund, L.P. has an estimated net worth of $486 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Dicerna Pharmaceuticals Inc, Invuity, Inc., DYNAVAX TECHNOLOGIES CORP, XERIS PHARMACEUTICALS INC, Invitae Corp, Auspex Pharmaceuticals, Inc., Fibrocell Science, Inc., TriVascular Technologies, Inc., CONSTELLATION PHARMACEUTICALS INC, NeurogesX Inc, Kiniksa Pharmaceuticals, Ltd., RIGEL PHARMACEUTICALS INC, eHealth, Inc., Nivalis Therapeutics, Inc., Shockwave Medical, Inc., Aclaris Therapeutics, Inc., Vanda Pharmaceuticals Inc., ANTARES PHARMA, INC., AERIE PHARMACEUTICALS INC, AVADEL PHARMACEUTICALS PLC, Axogen, Inc., ARVINAS INC., Neos Therapeutics, Inc., Loxo Oncology, Inc., NeuroMetrix, Inc., Avalanche Biotechnologies, Inc., Mirum Pharmaceuticals, Inc., ZAFGEN, INC., Cyclacel Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc., Recro Pharma, Inc., CATALYST BIOSCIENCES, INC., CytomX Therapeutics, Inc., CAS MEDICAL SYSTEMS INC, PROTEON THERAPEUTICS INC, AveXis, Inc., SteadyMed Ltd., Cabaletta Bio, Inc., aTYR PHARMA INC, ALIMERA SCIENCES INC, STREAMLINE HEALTH SOLUTIONS INC., Frequency Therapeutics, Inc., Audentes Therapeutics, Inc., Talon Therapeutics, Inc., NxStage Medical, Inc., HI TECH PHARMACAL CO INC, DUSA PHARMACEUTICALS INC, PAR PHARMACEUTICAL COMPANIES, INC., ANADYS PHARMACEUTICALS INC, XENOPORT INC, ISTA PHARMACEUTICALS INC, Somaxon Pharmaceuticals, Inc., NITROMED INC, VIA Pharmaceuticals, Inc., EMAGEON INC, THIRD WAVE TECHNOLOGIES INC /WI, and INSPIRE PHARMACEUTICALS INC.

SEC CIK

Deerfield Special Situations Fund, L.P.'s CIK is 0001354395

Past Insider Trading and Trends

2006 was Deerfield Special Situations Fund, L.P.'s most active year for acquiring shares with 124 total transactions. Deerfield Special Situations Fund, L.P.'s most active month to acquire stocks was the month of June. 2011 was Deerfield Special Situations Fund, L.P.'s most active year for disposing of shares, totalling 162 transactions. Deerfield Special Situations Fund, L.P.'s most active month to dispose stocks was the month of May. 2009 saw Deerfield Special Situations Fund, L.P. paying a total of $40,247,286.68 for 46,758,133 shares, this is the most they've acquired in one year. In 2007 Deerfield Special Situations Fund, L.P. cashed out on 1,885,903 shares for a total of $24,724,365.01, their largest year based on trade value.